Search Results 11-20 of 14861 for TNF

  1. Adrian T. Ting, Ph.D. - Mayo Clinic Faculty Profiles

    Ting's lab studies primarily post-translational mechanisms that dictate cell survival versus death in response to tumor necrosis factor (TNF). Even though TNF ...

  2. A Study To Assess Change In Disease Activity And Adverse Events Of Oral Upadacitinib In Adult And Adolescent Participants With Moderate To Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy - Mayo Clinic

    * Documented history of previous use of \>= 1 tumor necrosis factor (TNF) inhibitor for HS for at least 12 weeks and/or 1 approved non-anti-TNF biologic ...

  3. A Study Comparing the Safety of Tofacitinib versus Tumor Necrosis Factor Inhibitor in Patients with Rheumatoid Arthritis - Mayo Clinic

    The purpose of this post-marketing study is to compare the safety of tofacitinib versus tumor necrosis factor inhibitor with respect to major cardiovascular ...

  4. Mayo Clinic researchers to present study findings at American College of Gastroenterologists Annual Scientific Meeting

    Pardi. Anti-tumor necrosis factor (TNF) therapy linked to preeclampsia in women with inflammatory bowel disease. Women with inflammatory bowel disease have ...

  5. A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor - Mayo Clinic

    A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNF Alpha Inhibitor.

  6. A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors - Mayo Clinic

    A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis Patients Who Are Naive to TNF Inhibitors.

  7. A Study of CNTO 136 (Sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Patients With Active Rheumatoid Arthritis Despite Anti-TNF-Alpha Therapy (SIRROUND-T) - Mayo Clinic

    Have had anti-tumor necrosis factor (TNF)-alpha therapy and were unresponsive by 1 of the following 2 reasons: Lack of benefit to at least 1 anti-TNF-alpha ...

  8. Upadacitinib (oral route) - Side effects & dosage - Mayo Clinic

    ... tumor necrosis factor [TNF] blockers) that did not work well or cannot be tolerated. Upadacitinib is also used to treat moderate to severe atopic dermatitis ...

  9. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...

  10. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...